ArticleNucleic acids research2025
Control of the archaeal DNA damage-responsive pathway by phosphorylation of Orc1-2, the global regulator in Saccharolobus islandicus.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Review
- Sulfolobales: Acidothermophilic archaea as models for biology and biotechnological applications.Engineering microbiology · 2026Review
- Integration of ploidy, Orc1/Cdc6 homolog function, and lysine acetylation with phosphate limitation and UV stress responses of Haloferax volcanii.Extremophiles : life under extreme conditions · 2026Article
- An Lrs14 family protein functions as a nucleoid-associated protein regulating cell cycle progression in Sulfolobales.Communications biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Archaea employ Orc1-2, an Orc1/Cdc6 family protein, to mediate DNA damage-responsive (DDR) regulation, which orchestrates a series of cellular responses to DNA damage. However, how the DDR process is regulated remains elusive. To investigate whether the Orc1-2 functions could be regulated by posttranslational modifications (PTMs), differential PTMs were analyzed for Orc1-2 proteins in cells of normal growth versus those in DNA damage-treated cells. We found only Orc1-2 proteins present in untreated cells are phosphorylated at T356. Since T356 is located in the DNA-binding pocket of the archaeal DDR regulator in the predicted structure, its phosphorylation may impair the DNA binding of the protein. Indeed, characterization of T356A, the phospho-ablative form, and T356D, the phospho-mimetic form of Orc1-2, revealed that only the phospho-ablative form retained the specific DNA binding. Genetic characterization and RNA-seq analyses further revealed that their corresponding mutants also exhibited expected phenotypes: orc1-2T356D no longer exhibited DNA damage responses upon NQO treatment, while the phospho-ablative mutant orc1-2T356A is not only more tolerant to DNA damage agents but also prolongs the window of the DNA damage response. Taken together, these results indicated that T356 phosphorylation deactivates Orc1-2, thereby attenuating the archaeal DNA damage response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.